Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Increase in S-Shares by Controlling Shareholder

Issuer & Securities

Issuer/ Manager
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities
TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
05-Feb-2026 20:24:58
Status
New
Announcement Sub Title
Increase in S-Shares by Controlling Shareholder
Announcement Reference
SG260205OTHRBQ08
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
ANNOUNCEMENT ON THE INCREASE IN SHAREHOLDING OF S-SHARES OF THE COMPANY BY THE CONTROLLING SHAREHOLDER

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
05/02/2026

Attachments

05.02.2026 eFORM1-Guo Min.pdf
if you are unable to view the above file, please click the link below.
_05.02.2026 eFORM1-Guo Min.pdf
Total size =152K